Lifecore Biomedical Ownership | Who Owns Lifecore Biomedical?


OverviewForecastRevenueFinancialsChartTranscripts

Lifecore Biomedical Ownership Summary


Lifecore Biomedical is owned by 14.87% institutional investors, 5.46% insiders, and 79.68% retail investors. Wynnefield capital is the largest institutional shareholder, holding 13.69% of LFCR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.10% of its assets in Lifecore Biomedical shares.

LFCR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLifecore Biomedical14.87%5.46%79.68%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.69%10.91%62.39%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wynnefield capital4.70M13.69%$34.94M
Legion partners asset management4.43M12.90%$32.93M
Greenhaven road investment management3.62M10.52%$26.87M
325 capital2.16M6.29%$16.07M
22nw, lp1.76M5.11%$31.15M
Blackrock funding, inc. /de1.62M4.70%$12.01M
Vanguard group1.53M4.45%$11.37M
Geode capital management685.75K2.00%$5.10M
Invesco555.61K1.62%$4.13M
Dcf advisers539.99K1.57%$4.01M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
22nw, lp1.76M19.65%$31.15M
Legion partners asset management4.43M19.20%$32.93M
Wynnefield capital4.70M15.93%$34.94M
325 capital2.16M6.21%$16.07M
Greenhaven road investment management3.62M4.30%$26.87M
Dcf advisers539.99K1.94%$4.01M
Alpha wave global, lp116.54K0.40%$865.88K
Diametric capital, lp43.15K0.22%$320.57K
Lepercq multi-asset fund22.70K0.12%$168.66K
Lepercq de neuflize asset management22.70K0.12%$168.66K

Top Buyers

HolderShares% AssetsChange
Legion partners asset management4.43M19.20%1.46M
Greenhaven road investment management3.62M4.30%1.39M
325 capital2.16M6.21%792.68K
Invesco555.61K0.00%555.61K
Dcf advisers539.99K1.94%251.51K

Top Sellers

HolderShares% AssetsChange
Deutsche bank ag\25.43K0.00%-290.29K
Wynnefield capital4.70M15.93%-215.76K
B. riley asset management---143.48K
Boothbay fund management87.14K0.02%-100.00K
Marshall wace, llp133.19K0.00%-67.51K

New Positions

HolderShares% AssetsChangeValue
Invesco555.61K0.00%555.61K$4.13M
Alpha wave global, lp116.54K0.40%116.54K$865.88K
Massmutual trust co fsb/adv28.10K0.01%28.10K$208.78K
Lepercq multi-asset fund22.70K0.12%22.70K$168.66K
Lepercq de neuflize asset management22.70K0.12%22.70K$168.66K

Sold Out

HolderChange
Cove street capital-1.00
Capital performance advisors llp-2.00
Allspring global investments-64.00
Russell investments group-84.00
Lazard asset management-277.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202435-57.83%5,107,705-75.31%140.33%24-54.72%4-63.64%
Sep 30, 2024835.06%20,688,9251.65%671.50%5326.19%11-47.62%
Jun 30, 202479-3.66%20,352,578-5.60%661.34%42-2116.67%
Mar 31, 2024821.23%21,560,2731.63%701.46%4216.67%18-5.26%
Dec 31, 2023818.00%21,214,5086.91%691.64%3656.52%19-13.64%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF775.94K2.10%-
Vanguard Total Stock Mkt Idx Inv759.29K2.05%-
iShares Russell 2000 ETF613.31K1.66%-5.33K
Vanguard Institutional Extnd Mkt Idx Tr591.27K1.60%-
Invesco Dorsey Wright SmallCap Momt ETF417.94K1.13%-2.99K
Xtrackers S&P 500 2xLev Dly Swap ETF 1C315.72K0.86%-
Tocqueville200.00K0.65%-50.00K
iShares Russell 2000 Value ETF230.93K0.62%-
Fidelity Small Cap Index222.67K0.60%-4.17K
Fidelity Extended Market Index199.33K0.54%-1.27K

Recent Insider Transactions


DateNameRoleActivityValue
Jan 08, 2025Josephs Paul Chief Executive OfficerBuy$97.58K
Oct 03, 2024WYNNEFIELD PARTNERS SMALL CAP VALUE LP I-Buy$695.99K
Oct 03, 2024WYNNEFIELD PARTNERS SMALL CAP VALUE LP I-Buy$504.01K
Oct 03, 2024Kiper Christopher S Buy$623.62K
Oct 03, 2024Kiper Christopher S Buy$5.38M

Insider Transactions Trends


DateBuySell
2025 Q11-
2024 Q44-
2024 Q3--
2024 Q2--
2024 Q1--

LFCR Ownership FAQ


Who Owns Lifecore Biomedical?

Lifecore Biomedical shareholders are primarily institutional investors at 14.87%, followed by 5.46% insiders and 79.68% retail investors. The average institutional ownership in Lifecore Biomedical's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.69%, which Lifecore Biomedical falls below.

Who owns the most shares of Lifecore Biomedical?

Lifecore Biomedical’s largest shareholders are Wynnefield capital (4.7M shares, 13.69%), Legion partners asset management (4.43M shares, 12.90%), and Greenhaven road investment management (3.62M shares, 10.52%). Together, they hold 37.11% of Lifecore Biomedical’s total shares outstanding.

Does Blackrock own Lifecore Biomedical?

BlackRock is not among the top 10 institutional shareholders of Lifecore Biomedical.

Who is Lifecore Biomedical’s biggest shareholder by percentage of total assets invested?

22nw, lp is Lifecore Biomedical’s biggest shareholder by percentage of total assets invested, with 19.65% of its assets in 1.76M Lifecore Biomedical shares, valued at 31.15M$.

Who is the top mutual fund holder of Lifecore Biomedical shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Lifecore Biomedical shares, with 2.10% of its total shares outstanding invested in 775.94K Lifecore Biomedical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools